Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 2, 2002-07 ,pp. : 84-89

Karger

Access to resources Recommend Favorite

Galantamine for Alzheimer’s Disease and Mild Cognitive Impairment

By  

Neuroepidemiology, Vol. 28, Iss. 2, 2007-04 ,pp. : 116-117

Karger

Access to resources Recommend Favorite

Donepezil for the Treatment of Mild to Moderate Alzheimer’s Disease in France: The Economic Implications

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 1-2, 2003-12 ,pp. : 5-13

Karger

Access to resources Recommend Favorite

Differential Efficacy of Treatment with Acetylcholinesterase Inhibitors in Patients with Mild and Moderate Alzheimer’s Disease over a 6-Month Period

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 4, 2005-03 ,pp. : 189-195

Karger

Access to resources Recommend Favorite

Increased Levels of Adrenocortical and Gonadal Hormones in Mild to Moderate Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 2, 2002-02 ,pp. : 74-79

Karger

Access to resources Recommend Favorite